Save time and get answers to complex questions with AI chat
Does lipitor's effectiveness decrease with high fat meals?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Drugpatentwatch market analysis industry today?Xenazine current manufacturer 2025?Drug patent watch trametinib?
See the DrugPatentWatch profile for Osimertinib
Osimertinib is the generic name itself (it’s the nonproprietary drug name) for the EGFR-mutated non-small cell lung cancer medicine branded as Tagrisso.
You’ll most often encounter osimertinib under the brand name Tagrisso.
No. For small-molecule drugs like osimertinib, the “generic name” is the active ingredient name (osimertinib). There is no alternate generic name.
Other Questions About Osimertinib :